Your browser doesn't support javascript.
loading
A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation.
Lewsey, J D; Lawson, K D; Ford, I; Fox, K A A; Ritchie, L D; Tunstall-Pedoe, H; Watt, G C M; Woodward, M; Kent, S; Neilson, M; Briggs, A H.
Afiliación
  • Lewsey JD; Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Lawson KD; Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Ford I; Robertson Centre for Biostatistics, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Fox KA; BHF Centre for Research Excellence, University of Edinburgh, Edinburgh, UK.
  • Ritchie LD; Centre of Academic Primary Care, University of Aberdeen, University of Aberdeen, Aberdeen, UK.
  • Tunstall-Pedoe H; Institute of Cardiovascular Research, University of Dundee, Ninewells Hospital, Dundee, UK.
  • Watt GC; General Practice & Primary Care, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Woodward M; The George Institute for Global Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Kent S; Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Neilson M; Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
  • Briggs AH; Health Economics and Health Technology Assessment, Institute of Health & Wellbeing, University of Glasgow, Glasgow, UK.
Heart ; 101(3): 201-8, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25324535
ABSTRACT

OBJECTIVES:

A policy model is a model that can evaluate the effectiveness and cost-effectiveness of interventions and inform policy decisions. In this study, we introduce a cardiovascular disease (CVD) policy model which can be used to model remaining life expectancy including a measure of socioeconomic deprivation as an independent risk factor for CVD.

DESIGN:

A state transition model was developed using the Scottish Heart Health Extended Cohort (SHHEC) linked to Scottish morbidity and death records. Individuals start in a CVD-free state and can transit to three CVD event states plus a non-CVD death state. Individuals who have a non-fatal first event are then followed up until death. Taking a competing risk approach, the cause-specific hazards of a first event are modelled using parametric survival analysis. Survival following a first non-fatal event is also modelled parametrically. We assessed discrimination, validation and calibration of our model.

RESULTS:

Our model achieved a good level of discrimination in each component (c-statistics for men (women)-non-fatal coronary heart disease (CHD) 0.70 (0.74), non-fatal cerebrovascular disease (CBVD) 0.73 (0.76), fatal CVD 0.77 (0.80), fatal non-CVD 0.74 (0.72), survival after non-fatal CHD 0.68 (0.67) and survival after non-fatal CBVD 0.65 (0.66)). In general, our model predictions were comparable with observed event rates for a Scottish randomised statin trial population which has an overlapping follow-up period with SHHEC. After applying a calibration factor, our predictions of life expectancy closely match those published in recent national life tables.

CONCLUSIONS:

Our model can be used to estimate the impact of primary prevention interventions on life expectancy and can assess the impact of interventions on inequalities.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_cobertura_universal / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cardiovascular_diseases Asunto principal: Prevención Primaria / Enfermedades Cardiovasculares / Esperanza de Vida / Modelos Cardiovasculares Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Patient_preference Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Heart Asunto de la revista: CARDIOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 2_cobertura_universal / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cardiovascular_diseases Asunto principal: Prevención Primaria / Enfermedades Cardiovasculares / Esperanza de Vida / Modelos Cardiovasculares Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Patient_preference Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Heart Asunto de la revista: CARDIOLOGIA Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido
...